Literature DB >> 24648214

Low-dose aspirin ameliorated hyperlipidemia, adhesion molecule, and chemokine production induced by high-fat diet in Sprague-Dawley rats.

Hui-Li Lin1, Hsueh-Wei Yen, Su-Ling Hsieh, Li-Mei An, Kuo-Ping Shen.   

Abstract

In this study the effects of low-dose aspirin (5 mg/kg) on adhesion molecule and chemokine expression in a hyperlipidemic rat model. Six-week-old Sprague-Dawley (SD) rats were assigned to two control groups receiving either a regular diet or high-fat diet (HFD) and a treatment group fed HFD with 5 mg/kg aspirin for a 10-week period. Compared with the regular diet control group, the HFD control group had higher body weight, lower levels of high-density lipoprotein, higher concentrations of insulin, triglyceride, total cholesterol, and low-density lipoprotein, but no differences in blood glucose and glycated hemoglobin. The prothrombin time (PT) and activated partial thromboplastin time (aPTT) were clearly shortened in the HFD group. That group also had increased expression of intercellular adhesion molecule-1 (ICAM-1), ICAM-2, ICAM-3, vascular cell adhesion molecule (VCAM), platelet endothelial cell adhesion molecule (PECAM) and P-selectin in platelets and vascular adhesion protein-1 in lymphocyte and in aorta increased expressions of ICAM-1, ICAM-2, ICAM-3, VCAM, PECAM, E-selectin, monocyte chemoattractant protein-1 (MCP-1) and CCR2. The HFD rats also had increased PKCα, IκB kinase α (IKKα), p65, mitogen-activated protein kinases (MAPKs) (p38, c-Jun N-terminal kinases 1, extracellular signal-regulated kinase 1/2), and their phosphorylated forms. Low-dose aspirin improved HFD-induced hyperinsulinemia and hyperlipidemia, recovered PT and aPTT, inhibited upregulation of adhesion molecules and chemokines and reduced expression of PKCα, IKKα, p65, and MAPKs. Low-dose aspirin ameliorates HFD-induced hyperlipidemia and hyperinsulinemia, and prevents HFD-induced expression of adhesion molecules and chemokine formation.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  adhesion molecules and chemokines; aspirin; hyperlipidemia

Mesh:

Substances:

Year:  2013        PMID: 24648214     DOI: 10.1002/ddr.21159

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  14 in total

1.  A comparative study of the antithrombotic effect through activated endothelium of garlic powder and tomato extracts using a rodent model of collagen and epinephrine induced thrombosis.

Authors:  Leeseon Kim; Yeni Lim; Soo-Yeon Park; You Jin Kim; Oran Kwon; Jin Hee Lee; Jae-Ho Shin; Yoon Kyoung Yang; Ji Yeon Kim
Journal:  Food Sci Biotechnol       Date:  2018-09-18       Impact factor: 2.391

2.  Aspirin Inhibits Degenerative Changes of Aneurysmal Wall in a Rat Model.

Authors:  Shengjie Li; Dehui Wang; Ye Tian; Huijie Wei; Ziwei Zhou; Li Liu; Dong Wang; Jing-Fei Dong; Rongcai Jiang; Jianning Zhang
Journal:  Neurochem Res       Date:  2015-06-21       Impact factor: 3.996

3.  Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet.

Authors:  Isam Karam; Ning Ma; Xi-Wang Liu; Xiao-Jun Kong; Xiao-Le Zhao; Ya-Jun Yang; Jian-Yong Li
Journal:  Lipids Health Dis       Date:  2016-11-17       Impact factor: 3.876

4.  Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.

Authors:  Ning Ma; Xiwang Liu; Xiaojun Kong; Shihong Li; Zenghua Jiao; Zhe Qin; Pengcheng Dong; Yajun Yang; Jianyong Li
Journal:  Lipids Health Dis       Date:  2017-12-11       Impact factor: 3.876

5.  Let-7g suppresses both canonical and non-canonical NF-κB pathways in macrophages leading to anti-atherosclerosis.

Authors:  Yung-Song Wang; Edward Hsi; Hsin-Yun Cheng; Shih-Hsien Hsu; Yi-Chu Liao; Suh-Hang H Juo
Journal:  Oncotarget       Date:  2017-05-23

6.  Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero.

Authors:  Yi Zhou; Hui Peng; Zhimin Liu; Ke K Zhang; Chelsea Jendrusch; Madeline Drake; Yi Hao; Linglin Xie
Journal:  Lab Invest       Date:  2018-11-09       Impact factor: 5.662

7.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 8.  Endocan: A Key Player of Cardiovascular Disease.

Authors:  Jinzhi Chen; Liping Jiang; Xiao-Hua Yu; Mi Hu; Yang-Kai Zhang; Xin Liu; Pingping He; Xinping Ouyang
Journal:  Front Cardiovasc Med       Date:  2022-01-05

9.  Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls.

Authors:  Benjamin S Frank; Ludmila Khailova; Lori Silveira; Max B Mitchell; Gareth J Morgan; Elena W Y Hsieh; Michael V DiMaria; Mark Twite; Jelena Klawitter; Jesse A Davidson
Journal:  Transl Res       Date:  2020-10-09       Impact factor: 7.012

10.  Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.

Authors:  Isam Karam; Ning Ma; Xi-Wang Liu; Shi-Hong Li; Xiao-Jun Kong; Jian-Yong Li; Ya-Jun Yang
Journal:  BMC Vet Res       Date:  2015-08-20       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.